METASTATIC CHOLANGIOCARCINOMA AS A TARGET OF MOLECULAR-DIRECTED THERAPY. Вопр. онкол. 2018, 64 (5), 671-677. https://doi.org/10.37469/0507-3758-2018-64-5-671-677.